| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 10/13/2004 | CN1537001A Malonyl-COA decarboxylase inhibitors useful as metabolic modulators |
| 10/13/2004 | CN1536992A Carbamates of 2-heterocyclic-1, 2-ethanediols |
| 10/13/2004 | CN1535681A Application of dipeptide base peptidase IV effector for reducing blood sugar level of mammal |
| 10/13/2004 | CN1170813C N2 phenylamidine derivatives and fungicidal composition and use |
| 10/12/2004 | US6803384 Diaminopropionic acid derivatives |
| 10/12/2004 | CA2170394C Process for conditioning substances |
| 10/07/2004 | WO2004085388A2 Cyclic protein tyrosine kinase inhibitors |
| 10/07/2004 | WO2004084843A2 Inhibitors of cathepsin s |
| 10/07/2004 | WO2004084842A2 Inhibitors of cathepsin s |
| 10/07/2004 | WO2004043911A3 N-cycloalkylglycines as hiv protease inhibitors |
| 10/07/2004 | US20040198784 Antitumor agents for treating a tumor of the colon or rectum in a mammal; N-[2,4-dichlorobenzoyl]-5-bromothiophene-2-sulfonamide sodium salt |
| 10/07/2004 | US20040198783 Targeted bone marrow protection agents |
| 10/07/2004 | US20040198780 osteoporosis; antiarthritic agents; antidiabetic aghents; Alzheimer's disease; shock; central nervous system disorders; anticancer agents |
| 10/07/2004 | US20040198779 Antiinflammatory agents; adult respiratory distress syndrome |
| 10/07/2004 | US20040198774 Preventive and/or remedial agent for disease attributable to arteriosclerotic activity |
| 10/07/2004 | US20040198768 Method for inhibiting 5-lipoxygenase using a benzoxazole derivative or an analogue thereof |
| 10/07/2004 | US20040198741 Compounds, compositions and methods for treating or preventing viral infections and associated diseases |
| 10/07/2004 | US20040197879 1,2,3,4-tetrazol-1-yl-L-alanine or 1,2,3,4-tetrazol-2-yl-L-alanine. |
| 10/07/2004 | US20040197268 Alzheimer's disease therapy |
| 10/06/2004 | EP1463718A1 2-substituted thiazolidinone and oxazolidinone derivatives for the inhibition of phosphatases and the treatment of cancer |
| 10/06/2004 | EP1463715A1 Novel glucagon antagonists |
| 10/06/2004 | EP1463714A2 Vanilloid receptor ligands and their use in treatments |
| 10/06/2004 | EP1463502A1 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors |
| 10/06/2004 | EP1185521B1 Substituted 1-aza-2-imino-heterocycles and their use as activators of nicotinic acetylcholine receptors |
| 10/06/2004 | EP1169312B1 Glucokinase activators |
| 10/06/2004 | EP1140080B1 Use of riluzole for treating acoustic traumas |
| 10/06/2004 | EP1080082B1 Intermediates for the synthesis of epothilones and methods for their preparation |
| 10/06/2004 | CN1535271A Novel polymorphic forms of 5-[4-[2-[N-methyl-N-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2, 4-dione maleate and process for their preparation |
| 10/06/2004 | CN1535268A Thioflavin derivatives and their use in diagnosis and theraphy of alzheimer's disease |
| 10/06/2004 | CN1535267A 5-membered heterocycles, preparation and use thereof as medicine |
| 10/06/2004 | CN1535149A Topical application of thiazolyl amides |
| 10/06/2004 | CN1534028A New azadicyclo salt kind compound and its use in treating protein aging disease |
| 10/06/2004 | CN1534027A New substituted penta azacyclo salt kind compound and its use in treating protein ageing related disease |
| 10/06/2004 | CN1534021A Large conjugated half cyanine dye, its synthesis and its sensitized nano-crystal semiconductor solar energy battery |
| 10/06/2004 | CN1169800C Process for preparation of thiazole derivatives |
| 10/06/2004 | CN1169799C Method for production of thiazolidin |
| 10/05/2004 | US6800653 Anticancer agents |
| 10/05/2004 | CA2309439C 3-(3-hydroxyphenyl)-3-amino-propionamide derivatives |
| 10/05/2004 | CA2282834C Novel hexanoic acid derivatives |
| 10/05/2004 | CA2103836C 7-(substituted)-9-[(substituted glycyl)-amido]-6-demethyl-6-deoxytetracyclines |
| 09/30/2004 | WO2004083218A1 Guanidine derivatives and use thereof as neuropeptide ff receptor antagonists |
| 09/30/2004 | WO2004083195A1 Benzothiazole derivative compounds, compositions and uses |
| 09/30/2004 | WO2004050022B1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 09/30/2004 | WO2003072535A8 Substituted hydroxyethylamines |
| 09/30/2004 | US20040192926 Substituted indolyl quinolinone compounds; angiogenesis inhibitors; antitumor agents; atherosclerosis; vision defects; antidiabetic agents; antiinflammatory agents |
| 09/30/2004 | US20040192894 Compositions and methods related to fatty amino acid derivatives |
| 09/30/2004 | US20040192746 Anticancer agents; central nervous system disorders; sexual disorders; antidiabetic agents; obesity; muscular disorders; alopecia; sepsis; autoimmune disease |
| 09/30/2004 | US20040192745 Method of treating amytrophic lateral sclerosis using melatonin |
| 09/30/2004 | US20040192744 Inhibition of Histone Deacetylase; antiproliferative; antitumor: cell differentiation; 3,5-Dimethyl-isoxazole-4-carboxylic acid (2-amino-4,5-dichloro-phenyl)-amide |
| 09/30/2004 | US20040192740 for treating or preventing conditions associated with altered mitochondrial function with such compounds eg Alzheimer's Disease; diabetes mellitus; obesity; Parkinson's Disease; Huntington's disease; dystonia; Leber's hereditary optic neuropathy |
| 09/30/2004 | US20040192719 Peptide deformylase inhibitors |
| 09/30/2004 | US20040192703 Preferentially substituted calcium channel blockers |
| 09/30/2004 | US20040192702 Heteroaryl alkyl piperazine derivatives |
| 09/30/2004 | US20040192681 N-acylsulfonamide apoptosis promoters |
| 09/30/2004 | US20040192676 Ligands of melanocortin receptors and compositions and methods related thereto |
| 09/30/2004 | CA2518679A1 Guanidine derivatives and use thereof as neuropeptide ff receptor antagonists |
| 09/29/2004 | EP1462444A1 Intermediate for biotin and process for producing the same |
| 09/29/2004 | EP1462108A1 Interferon g (g) production promoter |
| 09/29/2004 | EP1461332A2 Production of chirally pure alpha-amino acids and n-sulfonyl alpha-amino acids |
| 09/29/2004 | EP1461326A1 Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors |
| 09/29/2004 | EP1461325A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/29/2004 | EP1461033A2 Methods and compositions for ameliorating the undesirable effects of chemotherapy |
| 09/29/2004 | EP0912533B1 Alkylaminobenzothiazole and -benzoxazole derivatives |
| 09/29/2004 | CN1533388A Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 09/29/2004 | CN1533382A 哌嗪衍生物 Piperazine derivatives |
| 09/29/2004 | CN1533374A Substitutled cyclohexane-1,4-diamine derivatives |
| 09/29/2004 | CN1533276A Use of thiazole derivatives for preparing medicine for protecting mitochondria |
| 09/29/2004 | CN1533275A Use of 4-[(4-thiazolyl) phenoxl] alkoxy-benzamidine derivatives for treatment of osteoporosis |
| 09/29/2004 | CN1168709C Alpha-hydroxy, amino and fluoro derivatives of beta-sulphenyl hdyroxamic acids matrix metalloproteinase inhibitors |
| 09/29/2004 | CN1168707C 4-guanidinobenzamides antifertility compounds |
| 09/28/2004 | US6797726 N-alkoxyalkyl-N,N-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same |
| 09/28/2004 | US6797723 Heterocycle substituted diphenyl leukotriene antagonists |
| 09/28/2004 | US6797717 Acyl coenzyme a cholesterol acyltransferase (acat) inhibitors |
| 09/28/2004 | CA2224125C Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride |
| 09/23/2004 | WO2004081643A1 Lenslet array with polarization conversion |
| 09/23/2004 | WO2004080996A1 Opioid receptor antagonists |
| 09/23/2004 | WO2004080985A1 3-(1-[3-(1,3-benzothiazol-6-yl)propylcarbamoyl]cycloalkyl)propanoic acid derivatives as nep inhibitors |
| 09/23/2004 | WO2004080984A1 Insecticidal phthalamide derivatives |
| 09/23/2004 | WO2004080947A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
| 09/23/2004 | WO2004080480A1 Pharmaceutical preparations comprising acid-stabilised insulin |
| 09/23/2004 | WO2004056399A3 Solid-phase fluorination of benzothiazoles |
| 09/23/2004 | WO2004050613A3 2-substituted-3-propenamide derivatives and methods of using the same |
| 09/23/2004 | WO2003082268A3 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 09/23/2004 | US20040186299 such as 3-(3,5-dimethoxyphenyl)-2-{4-[4-(2,4-dioxothiazolidin-5-ylmethyl)-phenoxy]-phenyl}-acrylic acid; for lowering blood glucose level, serum insulin, triglyceride and free fatty acid levels in animal models of Type II diabetes; for increasing leptin levels with no liver toxicity |
| 09/23/2004 | US20040186178 Amidino compounds useful as nitric oxide synthase inhibitors |
| 09/23/2004 | US20040186159 used to treat glaucomatous optic neuropathy and/or lower and control intraocular pressure (IOP) associated with normal-tension glaucoma, ocular hypertension, and/or glaucoma in warm blooded animals, including man |
| 09/23/2004 | US20040186154 treating or preventing a hypercholesterolemia-related or an inflammation-related condition ; apical sodium co-dependent bile acid transport inhibitor and an amount of a cyclooxygenase-2 (COX-2) selective inhibitor or its prodrug; kits |
| 09/23/2004 | US20040186151 E.g., 2-[3-(4'-Methoxyphenyl)-propionylamino]-2-(4'-n-butoxy-3'-carboxyphenyl)-2-ethyl[4-(4'-nitrophenyl)]imidazole; inhibitors of protein tyrosine phosphatases; antidiabetic, -carcinogenic, -inflammation agents; antiallergens; infections; modulation of growth hormones/factors; Alzeimer's; obesity |
| 09/23/2004 | US20040186150 4-{5-[4-(5-Isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy}-benzamidine or N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy}-benzamidine (DW-1350); a leukotriene-B4 receptor antangonist; inhibiting osteoclastic bone absorption |
| 09/23/2004 | US20040186146 E.g., R-N-2-[4-(pyrrolidin-1'-yl)methylphenyl]propionyl-methanesulfonamide; inhibition of chemotaxis of neutrophils induced by interleukin-8; antiinflammatory agents; psoriasis, ulcerative cholitis, glomerular nephritis, acute respiratory insufficiency, idiopathic fibrosis, and rheumatoid arthritis |
| 09/23/2004 | US20040186145 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 09/23/2004 | US20040186109 piperazine derivatives, e.g., (2R)-1-(2-methylbenzothiazol-5-yloxy)-3-[4-({5-[4-(trifluoromethyl)phenyl](4,5-dihydroisoxazol-3-yl)}methyl)piperazinyl]propan-2-ol; treating diabetes, arrhythmia, intermittent claudication, angina, congestive heart disease, and myocardial infarction |
| 09/23/2004 | US20040186098 Method for preventing and treating hearing loss using sensorineurotrophic compounds |
| 09/23/2004 | US20040186096 Drugs comprising phospholipase enzyme inhibitor; chemical synthesis; anaphylaxis, allergic inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease, ulcerative colitis, ischemia/reperfusion injuries, vasculitis |
| 09/23/2004 | US20040186080 Beta 2-adrenergic receptor agonists |
| 09/23/2004 | US20040186060 [1-(3-cyano-benzyl)-1-([[(5-cyano-thiophen-2-ylmethyl)-carbamoyl]-methyl]-carbamoyl)-3-methanesulfonyl-propyl]-carbamic acid methyl ester; trypsin-like serine protease; for treatment of tumors and metastasis cancer |
| 09/23/2004 | CA2519072A1 3-(1-[3-(1,3-benzothiazol-6-yl)propylcarbamoyl]cycloalkyl)propanoic acid derivatives as nep inhibitors |
| 09/23/2004 | CA2518986A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
| 09/23/2004 | CA2513791A1 Opioid receptor antagonists |
| 09/22/2004 | EP1460068A1 Process for producing 2-cyanoimino-1,3-thiazolidine |